As Fossil Group (FOSL) Stock Value Rose, Quinn Opportunity Partners Decreased Holding by $1.61 Million; Guyasuta Investment Advisors Lifted Its Position in Merck & Co (MRK) by $471,798

August 12, 2018 - By Billy Entrekin

Fossil Group, Inc. (NASDAQ:FOSL) Logo

Guyasuta Investment Advisors Inc increased its stake in Merck & Co Inc (MRK) by 13.46% based on its latest 2018Q1 regulatory filing with the SEC. Guyasuta Investment Advisors Inc bought 8,737 shares as the company’s stock rose 5.40% while stock markets declined. The institutional investor held 73,671 shares of the health care company at the end of 2018Q1, valued at $4.01M, up from 64,934 at the end of the previous reported quarter. Guyasuta Investment Advisors Inc who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $175.72B market cap company. The stock increased 0.11% or $0.07 during the last trading session, reaching $66.07. About 7.44M shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 9.15% since August 12, 2017 and is downtrending. It has underperformed by 21.72% the S&P500. Some Historical MRK News: 24/03/2018 – ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Societ; 18/05/2018 – FDA ISSUES ALERT ON ISSUE FOUND IN TRIALS ON KEYTRUDA,TECENTRIQ; 15/04/2018 – #AACR18 round 1: Merck takes a direct swing at Bristol-Myers with adjuvant melanoma data for Keytruda $MRK $BMY; 01/05/2018 – Merck Sees FY Adj EPS $4.16-Adj EPS $4.28; 13/03/2018 – FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA┬« (pembrolizumab) for; 09/05/2018 – New Study by Merck Animal Health Reveals Many Pet Parents Unprepared for the Dangers Posed by Fleas and Ticks; 27/03/2018 – MERCK & CO INC – JAPANESE MINISTRY OF HEALTH, LABOUR AND WELFARE GRANTS SAKIGAKE DESIGNATION FOR TEPOTINIB; 25/05/2018 – IMFINZI┬« (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non; 08/05/2018 – J&J’s Janssen: Darzalex Is the First Monoclonal Antibody Approved for Newly Diagnosed Patients With Newly Diagnosed Multiple Myeloma; 26/03/2018 – Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo Four-Week Dosing Schedule for Advanced

Quinn Opportunity Partners Llc decreased its stake in Fossil Group Inc (FOSL) by 89.94% based on its latest 2018Q1 regulatory filing with the SEC. Quinn Opportunity Partners Llc sold 134,178 shares as the company’s stock rose 47.41% while stock markets declined. The institutional investor held 15,000 shares of the consumer non-durables company at the end of 2018Q1, valued at $191,000, down from 149,178 at the end of the previous reported quarter. Quinn Opportunity Partners Llc who had been investing in Fossil Group Inc for a number of months, seems to be less bullish one the $1.15 billion market cap company. The stock decreased 6.12% or $1.52 during the last trading session, reaching $23.31. About 2.74M shares traded or 59.42% up from the average. Fossil Group, Inc. (NASDAQ:FOSL) has risen 74.05% since August 12, 2017 and is uptrending. It has outperformed by 61.48% the S&P500. Some Historical FOSL News: 25/04/2018 – Puma Signs Partnership With Fossil Group for Watches; 24/05/2018 – Mark R. Belgya Elected to Fossil Group, Inc. Board of Directors; 15/05/2018 – Scge Management Buys New 1.3% Position in Fossil; 08/05/2018 – Fossil Group Sees 2018 Restructuring Charges of About $55 M; 24/05/2018 – Fossil Group Announces Election of Mark Belgya to Board of Directors; 08/05/2018 – Fossil Group 1Q Loss/Shr 99c; 08/05/2018 – Fossil Group Provides 2Q Guidance and Updates Fiscal 2018 Guidance; 14/05/2018 – Pacifica Capital Investments LLC Exits Position in Fossil; 15/05/2018 – D E Shaw Buys New 1.8% Position in Fossil; 08/05/2018 – FOSSIL 1Q LOSS/SHR 99C, EST. LOSS/SHR 96C

More important recent Merck & Co., Inc. (NYSE:MRK) news were published by: 247Wallst.com which released: “Short Sellers Hike Bets in Major Pharma Stocks” on August 10, 2018, also Finance.Yahoo.com published article titled: “You Better Be Careful with Merck Stock, Especially at These Highs”, Benzinga.com published: “Merck Announces Plans To Cut Drug Prices” on July 20, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) was released by: 247Wallst.com and their article: “Merck Underwhelms Despite Beating Earnings” with publication date: July 27, 2018.

Guyasuta Investment Advisors Inc, which manages about $984.22 million and $854.06 million US Long portfolio, decreased its stake in L3 Technologies Inc by 6,628 shares to 130,889 shares, valued at $27.23 million in 2018Q1, according to the filing. It also reduced its holding in Microsoft Corp (NASDAQ:MSFT) by 27,447 shares in the quarter, leaving it with 366,296 shares, and cut its stake in Vanguard Index Fds (VTI).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 91 analyst reports since August 13, 2015 according to SRatingsIntel. As per Thursday, August 27, the company rating was upgraded by Berenberg. The firm earned “Hold” rating on Thursday, August 27 by Jefferies. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) rating on Friday, October 20. Jefferies has “Sell” rating and $55.0 target. Credit Suisse maintained Merck & Co., Inc. (NYSE:MRK) rating on Monday, May 9. Credit Suisse has “Neutral” rating and $57 target. On Tuesday, February 13 the stock rating was upgraded by DZ Bank to “Buy”. BMO Capital Markets maintained it with “Buy” rating and $7200 target in Friday, August 4 report. Credit Suisse maintained Merck & Co., Inc. (NYSE:MRK) on Wednesday, August 30 with “Outperform” rating. Deutsche Bank maintained Merck & Co., Inc. (NYSE:MRK) on Monday, July 17 with “Hold” rating. Leerink Swann maintained the shares of MRK in report on Monday, October 30 with “Market Perform” rating. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, February 7.

Investors sentiment increased to 1 in 2018 Q1. Its up 0.06, from 0.94 in 2017Q4. It increased, as 72 investors sold MRK shares while 603 reduced holdings. 114 funds opened positions while 561 raised stakes. 1.91 billion shares or 1.08% less from 1.93 billion shares in 2017Q4 were reported. Birch Hill Advsr Limited owns 652,424 shares or 2.94% of their US portfolio. Cibc Ww Markets holds 1.68 million shares or 0.97% of its portfolio. 251,157 were accumulated by Associated Banc. Liberty Capital Mgmt has 0.21% invested in Merck & Co., Inc. (NYSE:MRK). 5,314 were reported by Roberts Glore Company Il. Edgar Lomax Va holds 2.14% or 547,258 shares in its portfolio. M Hldg Secs invested in 0.41% or 24,873 shares. Tdam Usa has 142,678 shares for 0.47% of their portfolio. Merriman Wealth Management Limited Co has invested 0.07% in Merck & Co., Inc. (NYSE:MRK). Dean Associate Lc invested 0.21% in Merck & Co., Inc. (NYSE:MRK). Private Na holds 0.72% or 60,546 shares in its portfolio. Salem Capital Mgmt accumulated 113,494 shares. Hm Payson reported 401,034 shares stake. Putnam Fl Invest Management holds 32,887 shares. Essex Serv stated it has 0.34% in Merck & Co., Inc. (NYSE:MRK).

Quinn Opportunity Partners Llc, which manages about $778.53M US Long portfolio, upped its stake in China Mobile Ltd (NYSE:CHL) by 63,000 shares to 177,000 shares, valued at $8.10 million in 2018Q1, according to the filing. It also increased its holding in A by 2,000 shares in the quarter, for a total of 18,000 shares, and has risen its stake in General Motors Co (NYSE:GM).

Investors sentiment increased to 1.31 in Q1 2018. Its up 0.28, from 1.03 in 2017Q4. It improved, as 21 investors sold FOSL shares while 41 reduced holdings. 34 funds opened positions while 47 raised stakes. 43.96 million shares or 6.65% less from 47.10 million shares in 2017Q4 were reported. The Michigan-based Ls Inv Advsr Ltd Liability Corporation has invested 0% in Fossil Group, Inc. (NASDAQ:FOSL). State Teachers Retirement Systems stated it has 0% in Fossil Group, Inc. (NASDAQ:FOSL). Texas Permanent School Fund reported 28,661 shares or 0% of all its holdings. Metropolitan Life Ny holds 0% or 13,557 shares in its portfolio. Deutsche Bancshares Ag has invested 0% in Fossil Group, Inc. (NASDAQ:FOSL). Louisiana State Employees Retirement accumulated 0.01% or 19,200 shares. Parkside Finance Comml Bank And Tru has invested 0% in Fossil Group, Inc. (NASDAQ:FOSL). Commerzbank Aktiengesellschaft Fi holds 531,487 shares. Guggenheim Cap Ltd Liability Corporation reported 0% stake. Hsbc Holdg Public Ltd invested in 89,181 shares or 0% of the stock. Oz Mngmt Limited Partnership has invested 0.03% in Fossil Group, Inc. (NASDAQ:FOSL). Bridgeway Mgmt has 247,200 shares for 0.03% of their portfolio. Sg Americas Securities reported 116,980 shares. Wisconsin-based Convergence Inv Prns Ltd Liability Co has invested 0% in Fossil Group, Inc. (NASDAQ:FOSL). South Dakota Inv Council holds 0.01% or 24,600 shares in its portfolio.

Fossil Group, Inc. (NASDAQ:FOSL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts